貨號(hào):GS40737
Torudokimab is a humanized monoclonal antibody targeting interleukin-33 (IL-33), a cytokine released by epithelial and endothelial cells upon tissue damage. It binds to and neutralizes IL-33, blocking its interaction with the ST2 receptor to suppress type 2 inflammatory responses. It is being developed for the treatment of allergic and eosinophilic diseases, such as severe asthma and atopic dermatitis.
武漢邁思生物科技有限公司
聯(lián)系商家時(shí)請(qǐng)?zhí)峒癱hemicalbook,有助于交易順利完成!
冉凱凱